Table 5.

Acquisition of POEMS syndrome features over time

Patient characteristicsInitial POEMS featuresSubsequently acquired POEMS featuresTTP, yFU, yResponse
to therapy
Current status
No.SexAge, yPOEMSAB, no.CPap
66     Diff   Hypothyroid, hypoadrenal at 126 mo; ascites, pulmonary hypertension at 156 mo 10.5 14.5 V gd Alive 
34     2 or 3   Ascites, Budd-Chiari at 149 mo; pleural effusion at 156 mo 12.4 13.4 V gd Alive 
34    Diff   Detectable monoclonal protein in serum at 39 mo; hypothyroid at 60 mo; ascites and hepatomegaly at 87 mo 5.0 7.8 Stable Dead 
46   Diff   Pulmonary hypertension and effusion at 36 mo; hypothyroid at 52 mo; acrocyanosis at 54 mo 3.0 5.8 Good Alive 
58   Diff  Pap Hypothyroid at 9 mo; ascites and renal failure
at 12 mo 
0.8 3.3 Good Dead 
43    2 or 3   Hypoadrenal at 4 mo 0.3 1.0 Refr Alive 
50      Pericardial effusion at 1 mo 0.1 0.2 Refr Dead 
38     CHF, hypogonad, hypothyroid, hypoadrenal, peripheral edema, acrocyanosis, hypertrichosis, hyperpigmentation at 192 mo 16.0 16.4 V gd Alive 
33    Pap Peripheral edema at 90 mo 7.5 9.5 V gd Alive 
10 56   2 or 3   Diabetes mellitus at 94 mo 7.8 9.1 V gd Alive 
11 44    Pap Ascites and CHF at 56 mo 4.7 5.0 Good Dead 
12 51   Diff  Clubbing, ascites, and renal failure at 52 mo 4.3 4.9 ND Dead 
13 61   2 or 3   Ascites at 1 mo 0.1 0.7 ND Alive 
14 57 Diff   Ascites at 22 mo; renal failure and oxygen dependence at 117 mo 1.8 10.0 V gd Dead 
15 50  2 or 3  Pap Ascites at 12 mo; respiratory failure at 66 mo 1.0 5.7 Good Dead 
16 51  2 or 3   Hepatomegaly and hepatic dysfunction at 30 mo 2.5 2.8 Good Dead 
17 39    Lymphadenopathy at 17 mo; restrictive lung disease at 36 mo 1.4 1.4 Good Alive 
18 64 Diff  Pap Hypoparathyroid at 84 mo 7.0 14.6 Good Alive 
Patient characteristicsInitial POEMS featuresSubsequently acquired POEMS featuresTTP, yFU, yResponse
to therapy
Current status
No.SexAge, yPOEMSAB, no.CPap
66     Diff   Hypothyroid, hypoadrenal at 126 mo; ascites, pulmonary hypertension at 156 mo 10.5 14.5 V gd Alive 
34     2 or 3   Ascites, Budd-Chiari at 149 mo; pleural effusion at 156 mo 12.4 13.4 V gd Alive 
34    Diff   Detectable monoclonal protein in serum at 39 mo; hypothyroid at 60 mo; ascites and hepatomegaly at 87 mo 5.0 7.8 Stable Dead 
46   Diff   Pulmonary hypertension and effusion at 36 mo; hypothyroid at 52 mo; acrocyanosis at 54 mo 3.0 5.8 Good Alive 
58   Diff  Pap Hypothyroid at 9 mo; ascites and renal failure
at 12 mo 
0.8 3.3 Good Dead 
43    2 or 3   Hypoadrenal at 4 mo 0.3 1.0 Refr Alive 
50      Pericardial effusion at 1 mo 0.1 0.2 Refr Dead 
38     CHF, hypogonad, hypothyroid, hypoadrenal, peripheral edema, acrocyanosis, hypertrichosis, hyperpigmentation at 192 mo 16.0 16.4 V gd Alive 
33    Pap Peripheral edema at 90 mo 7.5 9.5 V gd Alive 
10 56   2 or 3   Diabetes mellitus at 94 mo 7.8 9.1 V gd Alive 
11 44    Pap Ascites and CHF at 56 mo 4.7 5.0 Good Dead 
12 51   Diff  Clubbing, ascites, and renal failure at 52 mo 4.3 4.9 ND Dead 
13 61   2 or 3   Ascites at 1 mo 0.1 0.7 ND Alive 
14 57 Diff   Ascites at 22 mo; renal failure and oxygen dependence at 117 mo 1.8 10.0 V gd Dead 
15 50  2 or 3  Pap Ascites at 12 mo; respiratory failure at 66 mo 1.0 5.7 Good Dead 
16 51  2 or 3   Hepatomegaly and hepatic dysfunction at 30 mo 2.5 2.8 Good Dead 
17 39    Lymphadenopathy at 17 mo; restrictive lung disease at 36 mo 1.4 1.4 Good Alive 
18 64 Diff  Pap Hypoparathyroid at 84 mo 7.0 14.6 Good Alive 

A indicates anasarca, edema, ascites, or pleural effusion; B, bone lesions; C, Castleman disease; CHF, congestive heart failure; Diff, diffuse; E, endocrinopathy; FU, follow-up; M, monoclonal plasma cell dyscrasia; ND, no data; O, organomegaly (including hepatomegaly, splenomegaly, and lymphadenopathy); P, peripheral neuropathy; Pap, papilledema; Refr, refractory disease; S, skin changes; TTP, time to progression; and V gd, very good.

or Create an Account

Close Modal
Close Modal